Expression and clinical significance of human leukocyte antigen class II, PD-1/PD-L1, and immune cells in small cell lung cancer
Yu Liu,Liping Zhang,Wei Zhang,Shengyu Wu,Bin Chen,Sha Zhao,Wei Li,Chenglong Sun,Lei Wang,Keyi Jia,Hao Wang,Peixin Chen,Chunyan Wu,Yayi He
DOI: https://doi.org/10.21203/rs.3.rs-34971/v1
2020-01-01
Abstract:Background
Human leukocyte antigen class II (HLA class II) is considered to be related to antitumor immunity. But its value in SCLC is still unclear. In this study, we analyzed HLA class II, programmed death receptor-1/programmed death receptor-1 (PD-1/PD-L1), and immune cells (CD3, CD4, CD8, FOXP3) expression and their role in predicting the patient’s prognosis in SCLC.
Methods
We analyzed 102 surgical SCLC tumor samples from Shanghai Pulmonary Hospital, China. HLA class II was detected by immunohistochemistry (IHC), and we analyzed the status of HLA class II protein expressed in SCLC. Correlation between HLA class II and PD-1/PD-L1, immune cells, clinicopathological variables, and the survival data were also studied.
Results
44.1% of patients expressed HLA class II on tumor-infiltrating lymphocytes (TILs) positively, yet only 5.9% of patients expressed it on SCLC tumor cells. HLA class II on TILs was positively related to PD-1, PD-L1 on TILs, and immune cells. On tumor cells, it also had a positive relationship with PD-1 on TILs (correction coefficient = 0.723, p = 0.006). Comparison of logistic regression models indicates that the odds ratios (ORs) for expression of HLA II on TILs were 3.233 (95% CI: 1.051 ~ 9.95, p = 0.041) when negative for PD-L1 on TILs were compared with those positive for PD-L1 on TILs, and 0.314 (95% CI: 0.118 ~ 0.838, p = 0.021) when negative lymph node metastasis was compared with that positive one. With the Cox regression model, the stage, HLA class II on TILs, PD-L1 on TILs, CD3, CD4, CD8, FOXP3 were considered as protective factors for relapse-free survival (RFS). HLA class II positive patients had a longer RFS (1.20 years, 95% CI: 0.83 ~ 1.57 versus. 3.40 years, 95% CI: 2.47 ~ 4.33, p = 0.015). The high level of HLA class II expressed on TILs was related to a better prognosis. The RFS of patients with positive HLA class II, PD-1/PD-L1, and immune cells was higher than that of these all negative patients (3.45 years, 95% CI: 2.92 ~ 3.97 versus. 2.02 years, 95% CI: 1.32 ~ 2.72, p = 0.001).
Conclusions
HLA class II was expressed on SCLC TILs, which was correlated with PD-1/PD-L1 and immune cells expression. HLA class II positive patient had a better prognosis.